FINDEX Inc. (TYO:3649)
Japan · Delayed Price · Currency is JPY 854.00
+30.00 (3.64%)
Oct 21, 2025, 3:30 PM JST
FINDEX Revenue
FINDEX had revenue of 1.17B JPY in the quarter ending June 30, 2025, with 8.55% growth. This brings the company's revenue in the last twelve months to 5.76B, down -6.28% year-over-year. In the year 2024, FINDEX had annual revenue of 5.84B with 12.52% growth.
Revenue (ttm)
5.76B
Revenue Growth
-6.28%
P/S Ratio
3.66
Revenue / Employee
18.52M
Employees
311
Market Cap
21.08B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 5.84B | 650.00M | 12.52% |
| Dec 31, 2023 | 5.19B | 650.00M | 14.31% |
| Dec 31, 2022 | 4.54B | -427.00M | -8.60% |
| Dec 31, 2021 | 4.97B | 964.00M | 24.08% |
| Dec 31, 2020 | 4.00B | -277.00M | -6.47% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Takeda Pharmaceutical Company | 4.48T |
| Otsuka Holdings | 2.40T |
| Astellas Pharma | 1.94T |
| Daiichi Sankyo Company | 1.92T |
| Chugai Pharmaceutical | 1.20T |
| Terumo | 1.04T |
| Olympus | 969.02B |
| HOYA Corporation | 876.09B |
FINDEX News
- 5 weeks ago - PE-backed Findex set to restock coffers with $400m refinancing - The Australian Financial Review